Bailard’s Erasca ERAS Stock Holding History

Bailard’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Hold	13,146	–	–	﹤0.01%	703
2026 Q1	$213K	Sell	13,146 -22,092	-63%	-$261K	﹤0.01%	699
2025 Q4	$131K	Buy	+35,238	New	+$99.1K	﹤0.01%	730
2024 Q1	–	Sell	-50,000	Closed	-$107K	–	758
2023 Q4	$107K	Buy	+50,000	New	+$105K	﹤0.01%	689

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bailard's ERAS Position: Q2 2026 in Review

Bailard held its Erasca (ERAS) position steady in Q2 2026 at 13,146 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Bailard first reported a position in ERAS in Q4 2023 and has held it in 4 quarters since. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

Bailard held 13,146 shares of Erasca worth $241K as of Q2 2026.
Bailard left its Erasca share count unchanged in Q2 2026.
Erasca made up ﹤0.01% of Bailard's portfolio in Q2 2026, its #703 holding.
Bailard first reported a position in Erasca in Q4 2023 and has held it in 4 quarters since.
257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.